Listening: Novartis criticises new US drug pricing rules
On Thursday, Novartis reiterated its claim that the US pricing of its Entresto drug was “unconstitutional”. Prices set under the White House’s Inflation Reduction Act (IRA) will limit access to medicine, the Basel firm says.
This content was published on
2 minutes
Keystone-SDA
Français
fr
Novartis critique les nouveaux prix fixés aux USA pour Entresto
Original
The price-setting process is “not objective or transparent” and does not reflect the true value of a drug, Novartis wrote in a press releaseExternal link. For the Basel-based pharmaceutical giant, the new prices set under US President Joe Biden’s IRA will also have “long-lasting and devastating consequences for patients by limiting access to medicines now and in the future”.
Currently, US patients pay an average of $29 (CHF25.24) a month for Entresto, a drug to treat heart failure. The IRA, a wide-ranging program of energy transition and social reform, plans to lower the prices of ten drugs for treating serious illnesses – including Entresto – after January 2026.
Under pressure, and despite strong reluctance, several major pharmaceutical companies, including Novartis, agreed to take part in negotiations with Medicare, the health insurance scheme for the over-65s in the United States.
“We acceded to a “maximum fair price” for Entresto for 2026 only to avoid other untenable options including catastrophic fines or the removal of all our products from both Medicare and Medicaid,” Novartis said in its press release.
Adapted from French by DeepL/dos
This news story has been written and carefully fact-checked by an external editorial team. At SWI swissinfo.ch we select the most relevant news for an international audience and use automatic translation tools such as DeepL to translate it into English. Providing you with automatically translated news gives us the time to write more in-depth articles.
If you want to know more about how we work, have a look here, if you want to learn more about how we use technology, click here, and if you have feedback on this news story please write to english@swissinfo.ch.
Popular Stories
More
Culture
Documentary portrays Swiss teenagers forced to return to parents’ homeland
Swiss cantons have killed 39 wolves so far this autumn
This content was published on
In mid-November, 35 packs of three or more wolves were detected in Switzerland. At least eight of them may be eliminated during the current hunting season. So far, at least 39 wolves have been shot in Graubünden, Valais, Vaud and St. Gallen.
This content was published on
Pierre-Yves Maillard, president of the Swiss Trade Union Confederation, sees no agreement in sight in negotiations with the European Union.
This content was published on
The "Dubai chocolate" has also caused a rush in Switzerland: queues formed outside the Lindt chocolate factory in Kilchberg, canton Zurich, on Saturday morning.
This content was published on
Stargazers currently have the chance to spot shooting stars in the night sky. Until November 30, the Leonid meteor shower is lighting up the darkness.
Nationalisation suggested to save Red Cross Museum
This content was published on
The director of the International Red Cross and Red Crescent Museum in Geneva is calling for a national debate on the institution's future.
Climate: 224 Swiss companies announce CO2 reduction targets
This content was published on
A total of 224 companies from Switzerland have joined the Science Based Targets initiative (SBTi), committing to CO2 reduction targets that are in line with the Paris Climate Agreement.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.